The American Medical Association has published the first set of COVID-19 vaccine and administration codes. The codes, which were recently approved by the CPT Editorial Panel, have a unique structure that will allow for tracking and accommodating multiple new COVID-19 vaccines. CPT immunization codes 90460-90474 will not be used for COVID-19.
The first codes are for vaccines produced by Pfizer and Moderna. Additional codes will be released as more COVID-19 vaccines are approved. Each will have its own vaccine code and administration codes. The Pfizer and Moderna vaccines require two doses, so each vaccine has two administration codes to indicate which dose was administered. The administration codes include counseling, when performed.
|Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use
• 0001A (1st dose)
• 0002A (2nd dose)
|Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use
• 0011A (1st dose)
• 0012A (2nd dose)
The AAFP is monitoring every aspect of the COVID-19 vaccine development process, including the Food and Drug Administration's Emergency Use Authorization reviews. Visit aafp.org/covidvaccine for updates to help prepare your practice and patients for the vaccines.
— Erin Solis, Manager of Practice and Payment at the American Academy of Family Physicians
Sign up to receive FPM's free, weekly e-newsletter, "Quick Tips & Insights," featuring practical, peer-reviewed advice for improving practice, enhancing the patient experience, and developing a rewarding career.